Support the show
Continuing the exploration of industry's influence on healthcare and health policy, in this episode of Causes or Cures, Dr. Eeks chats with Dr. Joel Lexchin and Dr. Lisa Parker about the influence drug companies have over patient groups. They will describe what patient groups are (why they are needed & the variety of work they do), why drug companies have a vested interest in patient groups, how drug companies fund and influence the groups (and sometimes even create them) and how the groups influence healthcare policy. They will also discuss practical things that can be done to make the overall health system put patients over profit.
Dr. Lexchin is a professor at York University, where he teaches pharmaceutical policy, an emergency medicine physician, a fellow of the Canadian Academy of Health Sciences, a member of the Ontario Drug Quality and Therapeutics Committee and was chair of the Drugs and Pharmacotherapy Committee of the Ontario Medical Association. Dr. Parker is an honorary senior lecturer at the School of Pharmacy at the University of Sydney and on the faculty of medicine and health. She is a clinician who practices in the field of oncology(cancer) and her research focuses on public health ethics and policy.
You can contact Dr. Eeks at bloomingwellness.com.
Follow Dr. Eeks on Instagram here.
Or Facebook here.
Subcribe to her newsletter here!